UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
 
FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
 
Date of Report (Date of earliest reported): March 7, 2011
 
Midas Medici Group Holdings, Inc.
(Exact name of registrant as specified in its charter)
 
Delaware
 
000-52621
 
37-1532843
(State or other jurisdiction of incorporation) 
 
Commission file number 
 
(IRS Employer Identification No.)
                                                                                                                  
445 Park Avenue, 20th Floor, New York, New York 10222
 
Registrant’s telephone number, including area code (212) 792-0920
 
Copies to:
Thomas Rose, Esq.
Marcelle S. Balcombe, Esq.
Sichenzia Ross Friedman Ference LLP
61 Broadway, 32nd Floor
New York, New York 10006
Phone: (212) 930-9700
Fax: (212) 930-9725
 
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
[_] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[_] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[_] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[_] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 
 

 
 
 
Item 5.02     Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
 
Effective March 7, 2011, Samuel Arthur and Keith Gordon resigned as Directors of Midas Medici Group Holdings, Inc. (the “Company”). There were no disagreements between the Company and each of Messrs.  Arthur and Gordon which led to their resignation.
 
 

 

 
 
 

 

 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
Midas Medici Group Holdings, Inc.
 
       
Date: March 10, 2011   
By:
/s/ Nana Baffour
 
   
Nana Baffour, CEO and
Co-Executive Chairman